Moleculin Biotech, Inc. (LON:0K2H)
London · Delayed Price · Currency is GBP · Price in USD 0.5529
+0.0194 (3.64%)
At close: Jul 11, 2025
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of 11.46 million as of July 17, 2025. Its market cap has increased by 78.12% in one year.
Market Cap
11.46M
Enterprise Value
6.06M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.55
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from 45.98M to 11.46M, a decrease of -75.07%. That is a compound annual growth rate of -14.12%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 165.33B |
| HSBC Holdings | 160.22B |
| Shell | 157.48B |
| Unilever | 111.66B |
| British American Tobacco p.l.c. | 82.86B |
| Rolls-Royce Holdings | 82.44B |
| Rio Tinto Group | 75.96B |
| RELX PLC | 72.94B |